Algovita Post-Market Clinical Study: Spinal Cord Stimulation to Treat Chronic Pain

NCT02373540 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 91

Last updated 2020-08-21

No results posted yet for this study

Summary

The purpose of this study is to obtain real-world clinical outcome data for the Algovita Spinal Cord Stimulation system when used, on-label, according to the applicable directions for use.

Conditions

Interventions

DEVICE

Algovita Spinal Cord Stimulation system

Sponsors & Collaborators

  • Bright Research Partners

    collaborator INDUSTRY
  • Nuvectra

    lead INDUSTRY

Principal Investigators

  • Ben Tranchina · Nuvectra

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2019-11-30
Completion
2019-11-30
FDA Device
Yes

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02373540 on ClinicalTrials.gov